Novartis is paying $1 billion upfront in a licensing deal for an experimental Huntington’s disease treatment from PTC ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

When County Executive David Crowley returned to college three years ago he only shared the news with family members and a few ...

There are two bills that have been passed by the Senate Finance Committee, the “Modernizing and Ensuring PBM Accountability ...

The detained people are suspected to be members of a drug smuggling syndicate aboard a mothership sailing in international ...

The narcotic farm promised a more humane approach to drug treatment, but the reality was more complicated, Oklahoma State ...

With e-cigarettes and flavored vapes booming in popularity, the Supreme Court will examine whether the FDA unlawfully blocked ...

PTC Therapeutics has signed an up to $2.9 billion licensing deal with Novartis AG for the U.S. company's experimental drug ...

IQVIA reported annual sales for the twelve months ending September 2024 of approximately $300 million for this product.

Whether you should be on heart attack medication depends on your medical history, such as having high blood pressure. Find a ...

It will be easier to spread out Part D drug costs over the year, while the total annual cost of medicines will be capped at ...

Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, ...